1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 6,150 | 6,300 | 08.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| AMPLITUDE SURGICAL Aktie jetzt für 0€ handeln | |||||
| 30.07. | XFRA 1AU: WIEDERAUFNAHME/RESUMPTION | 61 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 29.07. | Zydus Announces Completion of the Acquisition of an 85.6% Stake in Amplitude Surgical and Upcoming Filing of a Simplified Tender Offer | 270 | Business Wire | Regulatory News:
Zydus Lifesciences Limited1 ("Zydus"), on March 11, 2025, entered into agreements with PAI and two minority shareholders of Amplitude Surgical (Paris:AMPLI) to acquire blocks of... ► Artikel lesen | |
| 29.07. | XFRA 1AU: AUSSETZUNG/SUSPENSION | 126 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAMPLITUDE SURGIC.... ► Artikel lesen | |
| 29.07. | Amplitude Surgical - Suspension of Listing | 249 | Business Wire | Regulatory News:
Amplitude Surgical company has requested Euronext to suspend the listing of its shares (ISIN: FR0012789667, Ticker: AMPLI, eligible PEA-PME) on Euronext market with effect as from... ► Artikel lesen | |
| 24.07. | Amplitude Surgical - Consolidated annual revenue of €110.8 million, up +5.7% at constant exchange rates | 225 | Business Wire | Business growth of +3.8% at constant exchange rates in the fourth quarter of the 2024-25 financial year and of +5.7% for the full year
Strong momentum in France: revenue up +4.8%
Solid... ► Artikel lesen | |
| 25.04. | Zydus Lifesciences Limited Signs Purchase Agreement with PAI Partners and Other Shareholders to Acquire a Majority Stake in Amplitude Surgical SA | 369 | Business Wire | Regulatory News:
Amplitude Surgical SA (Paris:AMPLI):
Following the joint announcement of March 11, 2025, Zydus Lifesciences Limited ("Zydus") and Amplitude Surgical SA (Paris:AMPLI) ("Amplitude")... ► Artikel lesen | |
| 17.04. | Amplitude Surgical - 9-Months Consolidated Sales for FY 2024-25 of €83.8m, up +6.4% at Constant Exchange Rates | 295 | Business Wire | Sales up +6.6% at constant exchange rates in Q3 FY 2024-25
Consolidated sales for 9 months up+ 6.4% at constant exchange rates to €83.8m
Good momentum in France: sales up +4.7% over... ► Artikel lesen | |
| 17.04. | Zydus Lifesciences Limited announces the execution of undertakings to tender as part of its envisaged tender offer for Amplitude Surgical SA shares | 281 | PR Newswire | AHMEDABAD, India and PARIS, April 17, 2025 /PRNewswire/ -- Following the announcement of its envisaged tender offer on March 11, 2025, Zydus Lifesciences Limited announces the execution of... ► Artikel lesen | |
| 17.04. | Amplitude Surgical Has Been Informed by Zydus Lifesciences Limited of the Execution of Undertakings to Tender as Part of Its Envisaged Tender Offer for Amplitude Surgical SA Shares | 250 | Business Wire | Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible).
Following the announcement of the envisaged tender offer on March 11, 2025 of Zydus Lifesciences Limited... ► Artikel lesen | |
| 26.03. | Amplitude Surgical Announces H1 2024-25 Results: 51.5 M€ Sales and 13.1 M€ EBITDA | 374 | Business Wire | Consolidated sales of €51.5m, up 6.3% at constant exchange rates
EBITDA up 10.6% to €13.1 million, EBITDA margin 25.4%
Current operating income of €6.0 million
Cash position... ► Artikel lesen | |
| 12.03. | XFRA 1AU: WIEDERAUFNAHME/RESUMPTION | 215 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 11.03. | XFRA 1AU: AUSSETZUNG/SUSPENSION | 227 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAMPLITUDE SURGIC.... ► Artikel lesen | |
| 11.03. | Zydus Life inks pact to acquire majority stake in Amplitude Surgical | 2 | capitalmarket.com | ||
| 11.03. | Zydus Enters Exclusive Negotiations with PAI Partners and Other Shareholders to Acquire a Majority stake in Amplitude Surgical, France | 379 | Business Wire | Completion of the transaction to be followed by mandatory simplified tender offer
Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical,... ► Artikel lesen | |
| 20.02. | Amplitude Surgical - 1st Half-year 2024-25: Consolidated Sales of €51.5m, +6.3% at Constant Exchange Rates | 330 | Business Wire | Consolidated sales of €51.5 million, up+ 6.3% at constant exchange rates
Good sales growth in France at +4.6%
Strong growth in international business thanks to subsidiaries, with... ► Artikel lesen | |
| 21.11.24 | Amplitude Surgical - First Quarter 2024-25: Consolidated Sales of €21.8m, +7.5% at Constant Exchange Rates | 584 | Business Wire | VALENCE, France--(BUSINESS WIRE)--Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics... ► Artikel lesen | |
| 20.11.24 | Amplitude Surgical Announces Its 2024-25 Financial Calendar | 130 | Business Wire | Regulatory News:
Amplitude Surgical (ISIN: FR0012789667, Mnemo: AMPLI, PEA-PME eligible), the French market leader in surgical technologies for lower limb orthopedics, announces its financial agenda... ► Artikel lesen | |
| 23.10.24 | Amplitude Surgical - Fiscal Year 2023-24: 106.0 M€ Sales and €27.1m EBITDA | 505 | Business Wire | Consolidated sales of €106.0 million, up 6.3% at constant exchange rates
EBITDA up to €27.1m (+3.7%), EBITDA rate at 25.6%.
Current operating income of €12.7 million
Cash... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BICO GROUP | 3,236 | +0,19 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| PING AN HEALTHCARE | 1,388 | +1,28 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand | HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was held in Shanghai. Ping An Healthcare and... ► Artikel lesen | |
| ORGANON | 7,942 | +0,33 % | Organon & Co. - 10-Q, Quarterly Report | ||
| EMEIS | 12,960 | -0,54 % | emeis: Sales and Business Update at the End of June 20251 | Sustained growth in operating margins
Sustained revenue growth
+6.2% on a like-for-like basis
Net operational recovery
EBITDAR up nearly +20% on a like-for-like basis
EBITDA (excluding... ► Artikel lesen | |
| CYTOSORBENTS | 0,820 | -4,09 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., Aug. 7, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| CLARIANE | 4,334 | -0,32 % | Clariane: Tap issue in the amount of €100M of its notes due June 27th, 2030, bringing its total amount to €500m | Press release August 1st, 2025 Clariane has successfully completed a tap issue in the amount of 100 million euros of its notes due June 27, 2030, bringing its total amount to 500 million euros Paris... ► Artikel lesen | |
| ARJO | 2,918 | -0,41 % | Arjo AB: Andréas Elgaard appointed new President and CEO of Arjo | Arjo's Board of Directors has appointed Andréas Elgaard new President and CEO of the Group. Andréas most recently comes from the position as President and CEO of the publicly listed ITAB Shop Concept... ► Artikel lesen | |
| M3 INC | 12,600 | -1,56 % | Deutliches Plus erfreut Inhaber der M3-Aktie (12,50 €) | Grund zur Freude haben Aktionäre von M3 : Das Papier steigt deutlich. Zu den stärksten Werten des Tages gehört heute der Anteilsschein von M3 mit einem Wertanstieg von 11,61 Prozent. Für das Papier... ► Artikel lesen | |
| DYNAVOX GROUP | 11,620 | +0,35 % | Dynavox Group AB: Dynavox Group Interim Report second quarter 2025 | Dynavox Group AB (publ) today announced its results for the second quarter 2025.
Comment from the Dynavox Group CEO Fredrik Ruben:
Dynavox Group delivered another quarter of exceptional growth and... ► Artikel lesen | |
| NYXOAH | 6,250 | 0,00 % | EQS-News: Nyxoah SA.: Nyxoah erhält FDA-Zulassung für Genio®-System zur Behandlung von obstruktiver Schlafapnoe | EQS-News: Nyxoah SA.
/ Schlagwort(e): Zulassungsgenehmigung
Nyxoah erhält FDA-Zulassung für Genio®-System zur Behandlung von obstruktiver Schlafapnoe
08.08.2025 / 23:30... ► Artikel lesen | |
| INTERPACE BIOSCIENCES | 0,680 | 0,00 % | INTERPACE BIOSCIENCES, INC. - 8-K, Current Report | ||
| CHINA MEDICAL SYSTEM | 1,450 | 0,00 % | CMS (00867): NOTICE OF BOARD MEETING | ||
| NANOSONICS | 2,160 | -1,82 % | NANOSONICS LIMITED: FY25 Full Year Results webinar notification | ||
| VIVANI MEDICAL | 1,180 | 0,00 % | Vivani Medical, Inc.: Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 ... | LIBERATE-1, the first-in-human application of Vivani's NanoPortalTM implant technology, showed a positive safety and tolerability profile, along with encouraging performance data for NPM-115 that... ► Artikel lesen | |
| NIAGEN BIOSCIENCE | 8,450 | +1,20 % | Niagen Bioscience, Inc. - S-8, Securities to be offered to employees in employee benefit plans |
Das Unternehmen AMPLITUDE SURGICAL kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 6,150 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AMPLITUDE SURGICAL finden Sie auf Wallstreet Online.